S5 Ep21: Doctor, Cancer Survivor and Marathoner Goes the Distance for Her Patients: ‘Now I Can Just Give’
Cancer Horizons17 Touko 2023

S5 Ep21: Doctor, Cancer Survivor and Marathoner Goes the Distance for Her Patients: ‘Now I Can Just Give’

There’s no stopping Dr. Dawn Mussallem.

Mussallem — a lifestyle medicine and integrative breast cancer specialist at the Robert and Monica Jacoby Center for Breast Health at the Mayo Clinic in Jacksonville, Florida — is a cancer survivor, a recipient of both bone marrow and heart transplants, a mother and a marathon runner.

Mussallem explained to CURE® how her own life experiences have helped her connect with patients on health journeys of their own.

“Going through what you go through, it really gives you the ability to connect with people,” she said. “It's such a gift, that ability to connect, and really kind of be able to have a good sense or intuition, if you may, of where they're at in their cancer journey, and just to be able to be there with them, and that time of vulnerability. And so, it's given me the ability to have a good pulse on exactly where I need to be with a patient.”

When she was 26 and in the early months of medical school, Mussallem began experiencing shortness of breath and fatigue. One doctor told her she had asthma, another concurred and a third said it was all in her head. A few days later, she collapsed on her way home from class — she was in cardiogenic shock, and her heart wasn’t pumping.

Doctors found a 16-centimeter mass in her chest wrapped around her heart that had collapsed her left lung. She was diagnosed with stage 4, large diffuse B-cell non-Hodgkin’s lymphoma, and was told she had three months to live if she didn’t start treatment immediately, she recounted.

Surgery, chemotherapy and a bone marrow transplant followed. And life continued for her. She began her career in medicine, gave birth to a daughter who’s now 19 and, three weeks later, began experiencing heart failure.

Mussallem spent 18 years in heart failure. During that time, she stayed as active as possible, worked with her patients and volunteered at the National Marathon to Finish Breast Cancer operated by the DONNA Foundation, an organization which financially assists and supports patients with breast cancer and funds breast cancer research.

“I remember working here in the Breast Center with my breast cancer patients and volunteering at the DONNA Marathon because I couldn't run — I couldn't walk it with the heart failure,” Mussallem said. “And I remember just thinking, ‘Oh, my gosh, I would give anything one day to be able to run this. If or when I get a transplant, I'll be good enough to do that.’”

The transplant happened in February of 2021, and exactly one year to the day later, Mussallem crossed the marathon’s finish line.

In this episode of the “Cancer Horizons” podcast, Mussallem talks with CURE® about her DONNA Marathon training experience her connection with her patients and the importance of physical activity for patients during their cancer journey.

“For 18 years, I wanted to do what I did … but I had to hold back because I knew I only had so much to give,” she said. “And now I can just give and give and give because I feel great. I gotta get rid of my energy.”


For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.


Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(295)

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Joulu 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Maalis 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Syys 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Maalis 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Maalis 202410min

S6 Ep20: FDA Approvals from February 2024

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Helmi 20246min

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...

19 Helmi 20249min

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...

12 Helmi 20247min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-hereilla
rss-poliisin-mieli
tiedekulma-podcast
rss-duodecim-lehti
docemilia
hippokrateen-vastaanotolla
radio-antro
filocast-filosofian-perusteet
rss-ilmasto-kriisissa
rss-opeklubi
rss-kasvikutsut